RPL11 and anemia (phenotype): Demonstrating robust effects in vitro, these inhibitors also enhanced hematopoiesis and erythropoiesis in immunodeficient NPSG and NCG-X mice and various anemia models,21 including the Rpl11 haploinsufficiency mouse model of DBA.